US · Healthcare

Enzolytics Inc (ENZC)

Biotechnology

Enzolytics Inc (ENZC) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for ENZC

P/E ratio

18.00

Enzolytics Inc (ENZC) — FAQ

What is ENZC's P/E ratio?

The price-to-earnings (P/E) ratio for Enzolytics Inc (ENZC) is 18.00 (data as of 2026-03-24).

Does Enzolytics Inc pay a dividend?

Dividend yield is not available in the current snapshot for Enzolytics Inc (ENZC). Check the MyAverix Finance app for the latest dividend data.

What sector is Enzolytics Inc in?

Enzolytics Inc (ENZC) is classified in the Healthcare sector (Biotechnology industry).

What exchange is ENZC listed on?

ENZC is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)